实时全球研报
Silgan: Candor
研报英文原文证据摘录
Silgan: Candor
Jeffrey J. Zekauskas AC North America Equity Research
(1-212) 622-6644 30 July 2026 J P M O R G A N
jeffrey.zekauskas@jpmorgan.com
Price Performance Summary Investment Thesis and Valuation
Investment Thesis
Silgan is a leading, global manufacturer of rigid packaging
solutions for consumer goods. The company has contended with
several headwinds over the past few years, including customer
de-stocking in its food and beverage businesses, destocking in
its soup and pet food cans businesses, a shortage of skilled labor
at a domestic manufacturing facility, uncertain business trends
and higher interest rates. 2025 was a challenging year for Silgan
due to a customer bankruptcy proceeding, weather-driven
weakness in SLGN’s North American beverages business, and
YTD 1m 3m 12m customer inventory corrections in SLGN’s personal and home
Abs 5.6% -7.8% 7.8% -23.6% care businesses. Despite this, Silgan’s free cash flow remained
Rel -11.5% -4.3% 1.7% -53.1%
steady. Silgan should lap these headwinds in 2026 and we
Company Data continue to believe its volumes should inflect nicely in 2H:26;
Shares O/S (mn) 105 its free cash flow should grow modestly with EBITDA. We think
52-week range ($) 55.92-35.68 Silgan represents good value on this basis. We rate the shares
Market cap ($ mn) 4,486.73
Exchange rate 1.00 Overweight for year ahead performance. Our December 2027
Free float (%) 83.0% price target for Silgan shares of $48/sh implies an EV/EBITDA
3M ADV (mn) 1.05 multiple of 7.5x on our 2027 estimates and a 9% free cash flow
3M ADV ($ mn) 44.3
Volatility (90 Day) 36 yield.
Index RUSSELL 2000
BBG ANR (Buy | Hold | Sell) 12|2|0
Performance Drivers
Key Metrics (FYE Dec)
$ in millions FY25A FY26E FY27E FY28E
Financial Estimates
Revenue 6,483 6,925 7,075 7,135
Adj.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器